Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 4/2013

01-08-2013 | Case Report

Guillain–Barré syndrome and ulceroglandular tularemia

Authors: P. Ylipalosaari, T. I. Ala-Kokko, H. Tuominen, H. Syrjälä

Published in: Infection | Issue 4/2013

Login to get access

Abstract

Francisella tularensis is a small Gram-negative aerobic intracellular bacterium that should be considered as a possible pathogen in patients with fever, pharyngitis, and lymphadenopathia. Central nervous system manifestations have been rarely reported. We describe a patient who developed serious Guillain–Barré polyneuropathy as a rare complication of ulceroglandular tularemia.
Literature
1.
2.
Snowden J, Stovall S. Tularemia: retrospective review of 10 years’ experience in Arkansas. Clin Pediatr. 2011;50:64–8.CrossRef
3.
4.
5.
Ulu-Kilic A, Gulen G, Sezen F, Kilic S, Sencan I. Tularemia in central Anatolia. Infection. 2013;41:391–9.PubMedCrossRef
6.
Hofinger DM, Cardona L, Mertz GJ, Davis LE. Tularemic meningitis in the United States. Arch Neurol. 2009;66:523–7.PubMedCrossRef
7.
Gangat N. Cerebral abscesses complicating tularemia meningitis. Scand J Infect Dis. 2007;39:258–61.PubMedCrossRef
8.
van de Beek D, Steckelberg JM, Marshall WF, Kijpittayarit S, Wijdicks EFM. Tularemia with brain abscesses. Neurology. 2007;68:531.PubMedCrossRef
9.
Syrjälä H, Koskela P, Kujala P, Myllylä V. Guillain–Barré syndrome and tularemia pleuritis with high adenosine deaminase activity in pleural fluid. Infection. 1989;17:152–3.PubMedCrossRef
10.
Sutinen S, Syrjälä H. Histopathology of human lymph node tularemia caused by Francisella tularensis var palaearctica. Arch Pathol Lab Med. 1986;110:42–6.PubMed
11.
Syrjälä H, Schildt R, Räisäinen S. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis. 1991;10:68–70.PubMedCrossRef
12.
Ikäheimo I, Syrjälä H, Karhukorpi J, Schildt R, Koskela M. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J Antimicrob Chemother. 2000;46:287–90.PubMedCrossRef
13.
van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. IVIG treatment and prognosis in Guillain–Barré syndrome. J Clin Microbiol. 2010;30:S74–8.
14.
Contentin L, Soret J, Zamfir O, Gontier O, Lherm T, Hamrouni M, Ouchenir A, Monchamps G, Kalfon P. Francisella tularensis meningitis. Med Mal Infect. 2011;41:556–8.PubMedCrossRef
15.
Hughes RAC, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain–Barré syndrome: a systematic review. Brain. 2007;130:2245–57.PubMedCrossRef
16.
Rajabally YA. Treatment of Guillain–Barré syndrome: a review. Inflamm Allergy Drug Targets. 2012;11:330–4.PubMedCrossRef
17.
Metadata
Title
Guillain–Barré syndrome and ulceroglandular tularemia
Authors
P. Ylipalosaari
T. I. Ala-Kokko
H. Tuominen
H. Syrjälä
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0466-3

Other articles of this Issue 4/2013

Infection 4/2013 Go to the issue

Clinical and Epidemiological Study

The potential impact of biomarker-guided triage decisions for patients with urinary tract infections

Brief Report

Primary inoculation tuberculosis after an accidental scalpel injury

Correspondence

Bile microbiology at a hospital in southern Taiwan

Case Report

A rare case of Lemierre`s syndrome caused by Porphyromonas asaccharolytica

Brief Report

Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening

Case Report

Testicular mass: do not forget filariasis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits